First Immunotherapy To Treat Breast Cancer Approved By FDA
The Food and Drug Administration has approved the first immunotherapy drug for breast cancer.
Swiss drugmaker Roche’s Tecentriq was OK’d Friday for treating advanced triple-negative breast cancer, which accounts for about 15 percent of…
Read More...
Read More...